论文部分内容阅读
目的分析丙泊酚配伍舒芬太尼静脉麻醉应用于无痛人流术中的临床价值。方法选取2015年3月至2016年9月行无痛人流手术的患者300例作为研究对象,将其随机分成研究组(150例)和对照组(150例)。研究组给予丙泊酚配伍舒芬太尼静脉麻醉,对照组给予丙泊酚配伍芬太尼静脉麻醉。比较两组的手术指标、术后宫缩疼痛评分。结果研究组患者术后苏醒时间、丙泊酚用量、平均动脉压、心率、脉搏氧饱和度均优于对照组,差异有统计学意义(P<0.05)。研究组患者术后10、25、40 min的宫缩疼痛评分均优于对照组,差异有统计学意义(P<0.05)。结论丙泊酚配伍舒芬太尼静脉麻醉应用于无痛人流患者中麻醉效果显著,安全性高,患者疼痛时间较少,值得临床推广。
Objective To analyze the clinical value of propofol combined with sufentanil intravenous anesthesia in painless abortion. Methods A total of 300 patients with painless abortion from March 2015 to September 2016 were selected as study subjects and randomly divided into study group (150 cases) and control group (150 cases). Study group was given propofol with sufentanil intravenous anesthesia, the control group was given propofol with fentanyl intravenous anesthesia. Comparing the two groups of surgical indicators, postoperative contractions pain score. Results The recovery time, propofol dosage, mean arterial pressure, heart rate and pulse oxygen saturation of the study group were significantly higher than those of the control group (P <0.05). The pain scores of uterine contractions in study group at 10, 25 and 40 minutes after operation were all better than those in control group (P <0.05). Conclusion Propofol with sufentanil intravenous anesthesia applied to painless patients with significant anesthesia, high safety, less pain in patients with time, worthy of clinical promotion.